CN101112537A - Chinese traditional medicine preparations for treating hyperosteogeny disease - Google Patents
Chinese traditional medicine preparations for treating hyperosteogeny disease Download PDFInfo
- Publication number
- CN101112537A CN101112537A CNA2007100559627A CN200710055962A CN101112537A CN 101112537 A CN101112537 A CN 101112537A CN A2007100559627 A CNA2007100559627 A CN A2007100559627A CN 200710055962 A CN200710055962 A CN 200710055962A CN 101112537 A CN101112537 A CN 101112537A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- root
- chinese medicine
- rehmanniae preparata
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 9
- 235000008434 ginseng Nutrition 0.000 claims abstract description 9
- 241000271039 Agkistrodon Species 0.000 claims description 8
- 241000208340 Araliaceae Species 0.000 claims description 8
- 241000218176 Corydalis Species 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 8
- 241000180649 Panax notoginseng Species 0.000 claims description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 8
- 239000000463 material Substances 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 239000000843 powder Substances 0.000 abstract description 16
- 229940079593 drug Drugs 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 3
- 230000002496 gastric effect Effects 0.000 abstract description 3
- 230000001360 synchronised effect Effects 0.000 abstract description 2
- 241000208688 Eucommia Species 0.000 abstract 3
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 2
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 abstract 1
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 235000011202 Angiopteris lygodiifolia Nutrition 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000723185 Cyathea Species 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241000272060 Elapidae Species 0.000 abstract 1
- 241000305492 Gastrodia Species 0.000 abstract 1
- 241000501743 Gentiana macrophylla Species 0.000 abstract 1
- 244000018716 Impatiens biflora Species 0.000 abstract 1
- 235000015912 Impatiens biflora Nutrition 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 239000009759 San-Chi Substances 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 16
- 208000002193 Pain Diseases 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 11
- 210000003205 muscle Anatomy 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 238000005303 weighing Methods 0.000 description 9
- 230000003213 activating effect Effects 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 7
- 238000005728 strengthening Methods 0.000 description 7
- 229940126678 chinese medicines Drugs 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 208000031481 Pathologic Constriction Diseases 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 210000003461 brachial plexus Anatomy 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000036262 stenosis Effects 0.000 description 4
- 208000037804 stenosis Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 2
- 206010051326 Ligament calcification Diseases 0.000 description 2
- 208000016285 Movement disease Diseases 0.000 description 2
- 206010040026 Sensory disturbance Diseases 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010018634 Gouty Arthritis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000007103 Spondylolisthesis Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a traditional Chinese medicine preparation for treating hyperosteogeny disease, which is composed of tall gastrodia tuber, garden balsam stem, safflower, sanchi, Szechuan lovage rhizome, danshen root, ground beetle, yanhusuo, largeleaf gentian root, incised notopterygium rhizome, doubleteeth pubescent angilica root, little multibanded krait, cassia twig, eucommia bark, medicinal cyathula root, rhizome, radix rehmanniae preparata, east Asian tree fern rhizome, himalayan teasel root, tuber fleeceflower root (roasted), Chinese magnoliavine fruit, ginseng, nutgrass galingale rhizome, cassia bark and common clubmoss herb; except the radix rehmanniae preparata and the eucommia bark which have the greater viscosity, other 23 traditional Chinese medicines of the above medicines are weighed in proportion, the fine powder is obtained by passing through the 100 to 200 mesh screen, then the radix rehmanniae preparata and the eucommia bark are weighed in proportion and mixed evenly, then the fine powder is obtained by passing through the 100 to 200 mesh screen, so as to get the traditional Chinese medicine powder of the present invention. The present invention is the pure traditional Chinese medicine preparation and is characterized by treating both manifestation and root cause of disease, synchronous treatment and nourishing, no gastrointestinal adverse reactions, short treatment course, fast efficacy, high one-time cure rate, less toxicity and side effects, less rebound phenomenon after the cure, low cost and so on.
Description
Technical field
The present invention discloses a kind of Chinese medicine preparation for the treatment of hyperosteogeny disease, belongs to the Chinese medicine technical field.
Technical background
At present, the oral preparation of Chinese traditional medicinal of treatment hyperosteogeny is a lot of on the medical market, and therapeutic effect varies, and most of Chinese medicine preparation all have the different gastrointestinal side effect of degree, and therapeutic effect is also unsatisfactory, cures the symptoms, not the disease, and side effect is many, and is of common occurrence.
Summary of the invention
The present invention discloses a kind of Chinese medicine preparation for the treatment of hyperosteogeny disease, is pure Chinese medicinal preparation, and is evident in efficacy, shortens treatment cycle, reduces medical expense, improves therapeutic effect, simplifies Therapeutic Method.
The present invention is according to motherland's theory of Chinese medical science, pathogenesis and Therapeutic Principle in conjunction with hyperosteogeny disease, selected pure Chinese herbal medicine with expelling wind and removing dampness, dispelling cold by warming the meridian, supporing yang activating QI, blood circulation promoting and blood stasis dispelling, suppressing the hyperactive liver the kidney invigorating, bone and muscle strengthening, benefiting QI and nourishing blood, removing obstruction in the collateral to relieve pain is made pharmaceutical preparation by traditional Chinese medicine processing technology.
Concrete medicine is formed the column weight amount umber ratio of pressing:
Rhizoma Gastrodiae 38～50, Herba speranskiae tuberculatae 30～45, Radix Notoginseng 30～45, Flos Carthami 20～35,
Rhizoma Chuanxiong 35～45, Radix Salviae Miltiorrhizae 35～45, eupolyphage sece steleophaga 15～25, Rhizoma Corydalis 20～30,
Radix Gentianae Macrophyllae 20～30, Rhizoma Et Radix Notopterygii 20～35, Radix Angelicae Pubescentis 20～35, Agkistrodon 2～3,
Ramulus Cinnamomi 18～30, the Cortex Eucommiae 25～30, Radix Achyranthis Bidentatae 18～30, Rhizoma Polygonati 20～28,
Radix Rehmanniae Preparata 20～28, Rhizoma Cibotii 18～28, Radix Dipsaci 18～28, Radix Polygoni Multiflori (processing) 20～30,
Fructus Schisandrae Chinensis 18～28, Radix Ginseng 16～24, Rhizoma Cyperi 15～25, Cortex Cinnamomi 8～15,
Herba Lycopodii 30～45.
Preferred prescription is as follows:
Rhizoma Gastrodiae 45, Herba speranskiae tuberculatae 40, Flos Carthami 30, Radix Notoginseng 35, Rhizoma Chuanxiong 40, Radix Salviae Miltiorrhizae 40,
Eupolyphage sece steleophaga 20, Rhizoma Corydalis 25, Radix Gentianae Macrophyllae 25, Rhizoma Et Radix Notopterygii 25, Radix Angelicae Pubescentis 32, Agkistrodon 3,
Ramulus Cinnamomi 20, the Cortex Eucommiae 25, Radix Achyranthis Bidentatae 20, Rhizoma Polygonati 23, Radix Rehmanniae Preparata 25, Rhizoma Cibotii 20,
Radix Dipsaci 23, Radix Polygoni Multiflori (processing) 25, Fructus Schisandrae Chinensis 20, Radix Ginseng 18, Rhizoma Cyperi 15,
Cortex Cinnamomi 12, Herba Lycopodii 33.
Concrete processing procedure: except that Radix Rehmanniae Preparata, Cortex Eucommiae viscosity were big, all the other 23 flavor Chinese medicines took by weighing in proportion with said medicine, through 100～200 order fine powders, again the Radix Rehmanniae Preparata and the Cortex Eucommiae are taken by weighing in proportion uniform mixing, through 100～200 order fine powders, promptly obtain Chinese medicine powder of the present invention.
Take by weighing by per 5～10 gram portions, once a, a twice-daily, eliminating cold for resuscitation mouth of a river clothes in the meal, 30 days is a course of treatment.
This medicated powder can also be made tablet, capsule, the watered pill, honeyed pill and granule.
Side of the present invention separates with pharmacology analysis as follows:
Medicine of the present invention mostly is the medicine of blood circulation promoting and blood stasis dispelling, expelling wind and removing dampness, suppressing the hyperactive liver and subsiding YANG, bone and muscle strengthening, wherein: Rhizoma Gastrodiae: sweet, flat, the suppressing the hyperactive liver to relieve the wind syndrome relieving convulsion; Herba speranskiae tuberculatae: hot, warm, expelling wind and removing dampness, relaxing muscles and tendons to promote blood circulation.Pain relieving, two medicines 5 are played mutually altogether: the effect of expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation and stopping pain, suppressing the hyperactive liver the kidney invigorating is monarch drug altogether.The shared effect that can strengthen blood circulation promoting and blood stasis dispelling, expelling wind and removing dampness, dispelling cold by warming the meridian, supporing yang activating QI, benefiting QI and nourishing blood, suppressing the hyperactive liver the kidney invigorating, bone and muscle strengthening, removing obstruction in the collateral to relieve pain of 17 flavor Chinese medicines such as Flos Carthami, Radix Notoginseng, Rhizoma Chuanxiong, Rhizoma Corydalis, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Radix Ginseng, Rhizoma Cyperi, Cortex Cinnamomi, Radix Dipsaci, Radix Polygoni Multiflori, Herba Lycopodii, Fructus Schisandrae Chinensis, Rhizoma Cibotii, the Cortex Eucommiae, Radix Rehmanniae Preparata, Agkistrodon is ministerial drug altogether.4 flavor Chinese medicines such as Radix Salviae Miltiorrhizae, eupolyphage sece steleophaga, Rhizoma Polygonati, Radix Gentianae Macrophyllae are adjuvant drug, the shared effect that can strengthen blood circulation promoting and blood stasis dispelling, removing obstruction in the collateral to relieve pain, clearing away heat-damp and promoting diuresis, life essence-filling, marrow-benefitting, benefiting QI and nourishing blood, suppressing the hyperactive liver the kidney invigorating.Radix Achyranthis Bidentatae: bitter, acid, flat, invigorating the liver and kidney, bone and muscle strengthening, eliminating blood stasis and inducing menstruation, conducting blood to flow downwards: Ramulus Cinnamomi: hot, warm, relieving the exterior syndrome by diaphoresis, warming the meridian and promoting blood circulation, supporing yang activating QI, two medicines mutually 5 increase promoting the flow of QI in the collateral by warming the meridian, blood circulation promoting and blood stasis dispelling jointly, dispel the wind and carry the effect of few, suppressing the hyperactive liver the kidney invigorating, bone and muscle strengthening, relaxing muscles and tendons and activating QI and blood in the collateral, be messenger drug altogether, play all medicine effects of guiding.
More than 25 flavor Chinese medicines shared, can reach the effect of expelling wind and removing dampness, dispelling cold by warming the meridian, supporing yang activating QI, blood circulation promoting and blood stasis dispelling, suppressing the hyperactive liver the kidney invigorating, bone and muscle strengthening, benefiting QI and nourishing blood, removing obstruction in the collateral to relieve pain.
Differential diagnosis in tcm: wind chill blockage, cold-damp resistance network, phlegm-damp intrinsic heat, qi depression to blood stasis, muscle lose and moisten foster, deficiency of qi and blood, caused by liver and kidney deficiency, kidney yang deficiency.
Indication: expelling wind and removing dampness, dispelling cold by warming the meridian, activating blood circulation and supplementing qi, removing obstruction in the collateral to relieve pain, suppressing the hyperactive liver the kidney invigorating, bone and muscle strengthening.
Be mainly used in: various hyperosteogenys, ligament calcification and rheumatism.Comprise vertebrae hyperosteogeny, intervertebral disk hernia, spinal canal stenosis, ankylosing spondylitis, gouty arthritis, ligamenta intervertebralia calcification, intervertebral foramina stenosis, mismatch of thoracis vertbra small joint, lumbar spondylolisthesis etc.Can also be used for each arthralgia that rheumatism and rheumatism cause, hyperosteogeny etc.
Good effect of the present invention is: has treating both the principal and secondary aspects of a disease, controls and mend synchronous, no gastrointestinal side effect, and short treating period, rapid-action, the one-time cure rate height, toxic and side effects is little, controls characteristics such as afterwards rebound phenomena is few, and expense is low.
For showing the therapeutic effect of medicine of the present invention, selected 104 routine patients treat with medicine of the present invention, carry out statistical analysis through system's clinical observation and are summarized as follows:
Diagnosis basis:
(1) x line, cR sheet, cT sheet, the diagnosis of MRI sheet;
(2) the various clinical symptoms of doctor trained in Western medicine case regulation.
Diagnostic criteria:
Cure: various clinical symptom disappearance.
Effectively: various clinical symptoms are obviously improved.
Invalid: various clinical symptoms do not have improvement.
The 104 routine hyperosteogeny patients that use Drug therapy of the present invention are carried out statistical analysis, cure 83 examples, cure rate is 79.9%; Produce effects 12 examples; Effective 7 examples (2 example allergy are wherein arranged); Total effective rate is 98.1%.Invalid 2 examples, inefficiency are 1.9%.
Case 1: Pan xx, man, 64 years old, cervical vertebra 3～7 joint hyperosteogenys, the ligament calcification is before the treatment: dizziness, cardiopalmus, unstable blood pressure (+), restriction of neck motion, snap (+), go up angle tenderness, radiating pain (+) in right hand numbness, the right omoplate, brachial plexus distraction test (+), pressure head test (+).Treatment back: dizziness, cardiopalmus, unstable blood pressure
(-), restriction of neck motion, snap (-) are gone up angle tenderness, radiating pain (-) in right hand numbness, the right omoplate, brachial plexus distraction test (-), pressure head test (-).
Case 2: certain man, 62 years old, cervical vertebra 3～4 joint hyperosteogenys, companion's spinal canal stenosis, before the treatment: dizzy, headache (+), cardiopalmus, breathe hard (+), unstable blood pressure (+), the cervical region activity is seriously limited, snap (+), the following sensory disturbance of cervical vertebra 3～4 pitch planes, movement disorder (+), pressure head test (+), brachial plexus distraction test (+).
The treatment back: dizzy, headache (-), cardiopalmus, breathe hard (-), unstable blood pressure (-), the cervical region activity is seriously limited, snap (-), the following sensory disturbance of cervical vertebra 3～4 pitch planes, movement disorder (-), pressure head test (-), brachial plexus distraction test (-).
Case 3: certain man, 60 years old, lumbar vertebra 3～4 internode dish bulgings, companion's lumbar vertebra 3～caudal vertebra 1 hyperosteogeny, lumbar vertebra 5～caudal vertebra 1 spinal canal stenosis.Before the treatment: deadlock in morning (+), alternately walk lamely (+), body deflection (+), the other tenderness of vertebra, radiating pain (+), waist hyperextension test (+), straight lower limb is raised and applied voltage test (+) pick-up test (+) of bending over.The treatment back: deadlock in morning (-), alternately walk lamely (-), body deflection (-), the other tenderness of vertebra, radiating pain (-), waist hyperextension test (-), straight lower limb is raised and applied voltage test (-) pick-up test (-) of bending over.
Above case was followed up a case by regular visits to after 1 year, all not recurrence.
The specific embodiment
For the ease of understanding the present invention, especially exemplified by following examples.Its effect is understood that it is to explaination of the present invention but not to any type of restriction of the present invention.
Embodiment 1
Take by weighing following medicine (unit: kilogram): Rhizoma Gastrodiae 45, Herba speranskiae tuberculatae 40, Flos Carthami 30, Radix Notoginseng 35, Rhizoma Chuanxiong 40, Radix Salviae Miltiorrhizae 40, eupolyphage sece steleophaga 20, Rhizoma Corydalis 25, Radix Gentianae Macrophyllae 25, Rhizoma Et Radix Notopterygii 25, Radix Angelicae Pubescentis 32, Agkistrodon 3, Ramulus Cinnamomi 20, the Cortex Eucommiae 25, Radix Achyranthis Bidentatae 20, Rhizoma Polygonati 23, Radix Rehmanniae Preparata 25, Rhizoma Cibotii 20, Radix Dipsaci 23, Radix Polygoni Multiflori (system) 25, Fructus Schisandrae Chinensis 20, Radix Ginseng 18, Rhizoma Cyperi 15, Cortex Cinnamomi 12, Herba Lycopodii 33.
Concrete processing procedure: except that Radix Rehmanniae Preparata, Cortex Eucommiae viscosity were big, all the other 23 flavor Chinese medicines took by weighing in proportion, through 100～200 order fine powders, the Radix Rehmanniae Preparata and the Cortex Eucommiae are taken by weighing in proportion again, and uniform mixing through 100～200 order fine powders, promptly obtains Chinese medicine powder of the present invention.
Embodiment 2
(unit: kilogram): Rhizoma Gastrodiae 38, Herba speranskiae tuberculatae 30, Flos Carthami 25, Radix Notoginseng 35, Rhizoma Chuanxiong 35, Radix Salviae Miltiorrhizae 45, eupolyphage sece steleophaga 15, Rhizoma Corydalis 20, Radix Gentianae Macrophyllae 20, Rhizoma Et Radix Notopterygii 35, Radix Angelicae Pubescentis 20, Agkistrodon 2, Ramulus Cinnamomi 30, Radix Achyranthis Bidentatae 18, Rhizoma Polygonati 20, Rhizoma Cibotii 25, Radix Dipsaci 25, Radix Polygoni Multiflori (system) 20, Fructus Schisandrae Chinensis 18, Radix Ginseng 24, Rhizoma Cyperi 25, Cortex Cinnamomi 8, Herba Lycopodii 45 are ground into 100～200 order fine powders with following medicine, with Radix Rehmanniae Preparata 20, the Cortex Eucommiae 30 uniform mixing, through 100～200 order fine powders, promptly obtain Chinese medicine powder of the present invention.
Embodiment 3
Take by weighing following medicine (unit: kilogram): Rhizoma Gastrodiae 50, Herba speranskiae tuberculatae 45, Flos Carthami 35, Radix Notoginseng 45, Rhizoma Chuanxiong 45, Radix Salviae Miltiorrhizae 35, eupolyphage sece steleophaga 25, Rhizoma Corydalis 30, Radix Gentianae Macrophyllae 30, Rhizoma Et Radix Notopterygii 20, Radix Angelicae Pubescentis 30, Agkistrodon 3, Ramulus Cinnamomi 20, the Cortex Eucommiae 28, Radix Achyranthis Bidentatae 30, Rhizoma Polygonati 28, Radix Rehmanniae Preparata 28, Rhizoma Cibotii 28, Radix Dipsaci 18, Radix Polygoni Multiflori (system) 30, Fructus Schisandrae Chinensis 28, Radix Ginseng 16, Rhizoma Cyperi 20, Cortex Cinnamomi 8, Herba Lycopodii 45.
Concrete processing procedure: except that Radix Rehmanniae Preparata, Cortex Eucommiae viscosity were big, all the other 23 flavor Chinese medicines took by weighing in proportion, through 100～200 order fine powders, the Radix Rehmanniae Preparata and the Cortex Eucommiae are taken by weighing in proportion again, and uniform mixing through 100～200 order fine powders, promptly obtains Chinese medicine powder of the present invention.
Claims (3)
1. Chinese medicine preparation for the treatment of hyperosteogeny disease is characterized in that it being to be made by following materials of weight proportions medicine:
Rhizoma Gastrodiae 38～50, Herba speranskiae tuberculatae 30～45, Radix Notoginseng 30～45, Flos Carthami 20～35,
Rhizoma Chuanxiong 35～45, Radix Salviae Miltiorrhizae 35～45, eupolyphage sece steleophaga 15～25, Rhizoma Corydalis 20～30,
Radix Gentianae Macrophyllae 20～30, Rhizoma Et Radix Notopterygii 20～35, Radix Angelicae Pubescentis 20～35, Agkistrodon 2～3,
Ramulus Cinnamomi 18～30, the Cortex Eucommiae 25～30, Radix Achyranthis Bidentatae 18～30, Rhizoma Polygonati 20～28,
Radix Rehmanniae Preparata 20～28, Rhizoma Cibotii 18～28, Radix Dipsaci 18～28, Radix Polygoni Multiflori (processing) 20～30,
Fructus Schisandrae Chinensis 18～28, Radix Ginseng 16～24, Rhizoma Cyperi 15～25, Cortex Cinnamomi 8～15,
Herba Lycopodii 30～45.
2. Chinese medicine preparation according to claim 1 is characterized in that it being to be made by following materials of weight proportions medicine:
Rhizoma Gastrodiae 45, Herba speranskiae tuberculatae 40, Flos Carthami 30, Radix Notoginseng 35, Rhizoma Chuanxiong 40, Radix Salviae Miltiorrhizae 40,
Eupolyphage sece steleophaga 20, Rhizoma Corydalis 25, Radix Gentianae Macrophyllae 25, Rhizoma Et Radix Notopterygii 25, Radix Angelicae Pubescentis 32, Agkistrodon 3,
Ramulus Cinnamomi 20, the Cortex Eucommiae 25, Radix Achyranthis Bidentatae 20, Rhizoma Polygonati 23, Radix Rehmanniae Preparata 25, Rhizoma Cibotii 20,
Radix Dipsaci 23, Radix Polygoni Multiflori (processing) 25, Fructus Schisandrae Chinensis 20, Radix Ginseng 18, Rhizoma Cyperi 15,
Cortex Cinnamomi 12, Herba Lycopodii 33.
3. Chinese medicine preparation according to claim 1 and 2 is a said dosage form on any pharmaceutics.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100559627A CN100566742C (en) | 2007-08-15 | 2007-08-15 | The Chinese medicine preparation of treatment hyperosteogeny disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100559627A CN100566742C (en) | 2007-08-15 | 2007-08-15 | The Chinese medicine preparation of treatment hyperosteogeny disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101112537A true CN101112537A (en) | 2008-01-30 |
| CN100566742C CN100566742C (en) | 2009-12-09 |
Family
ID=39021167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2007100559627A Expired - Fee Related CN100566742C (en) | 2007-08-15 | 2007-08-15 | The Chinese medicine preparation of treatment hyperosteogeny disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100566742C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526540A (en) * | 2012-03-21 | 2012-07-04 | 刘金鑫 | Medicinal composition with effect of relieving pain of main and collateral channels |
| CN102772617A (en) * | 2012-02-16 | 2012-11-14 | 王建国 | Medicine for treating disease of hyperosteogeny |
| CN103479837A (en) * | 2013-09-02 | 2014-01-01 | 张金学 | External medicine for curing hyperosteogeny and preparation method thereof |
| CN104324340A (en) * | 2014-12-03 | 2015-02-04 | 汤玮 | Traditional Chinese medicine preparation for treating calcaneal bone hyperplasia and preparation method of traditional Chinese medicine preparation |
| CN105797110A (en) * | 2016-04-21 | 2016-07-27 | 广西嘉进药业股份有限公司 | Traditional Chinese medicine composition for treating osteoarticular diseases and preparation method thereof |
| CN109106918A (en) * | 2018-11-08 | 2019-01-01 | 邹正年 | A kind of Chinese medicine and preparation method thereof for treating rheumatism bone disease |
-
2007
- 2007-08-15 CN CNB2007100559627A patent/CN100566742C/en not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102772617A (en) * | 2012-02-16 | 2012-11-14 | 王建国 | Medicine for treating disease of hyperosteogeny |
| CN102772617B (en) * | 2012-02-16 | 2014-05-14 | 王建国 | Medicine for treating disease of hyperosteogeny |
| CN102526540A (en) * | 2012-03-21 | 2012-07-04 | 刘金鑫 | Medicinal composition with effect of relieving pain of main and collateral channels |
| CN103479837A (en) * | 2013-09-02 | 2014-01-01 | 张金学 | External medicine for curing hyperosteogeny and preparation method thereof |
| CN103479837B (en) * | 2013-09-02 | 2015-07-22 | 张金学 | External medicine for curing hyperosteogeny and preparation method thereof |
| CN104324340A (en) * | 2014-12-03 | 2015-02-04 | 汤玮 | Traditional Chinese medicine preparation for treating calcaneal bone hyperplasia and preparation method of traditional Chinese medicine preparation |
| CN104324340B (en) * | 2014-12-03 | 2017-07-14 | 汤玮 | It is a kind of to treat Chinese medicine preparation of heel bone hyperosteogeny and preparation method thereof |
| CN105797110A (en) * | 2016-04-21 | 2016-07-27 | 广西嘉进药业股份有限公司 | Traditional Chinese medicine composition for treating osteoarticular diseases and preparation method thereof |
| CN109106918A (en) * | 2018-11-08 | 2019-01-01 | 邹正年 | A kind of Chinese medicine and preparation method thereof for treating rheumatism bone disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100566742C (en) | 2009-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100423761C (en) | Chinese medicinal preparation for treating fracture, traumatic injury | |
| CN100566742C (en) | The Chinese medicine preparation of treatment hyperosteogeny disease | |
| CN103735641B (en) | Medicine for the treatment of fracture and preparation method thereof | |
| CN1539479A (en) | Drug for curing disease of proplapse of lumbar intervertebral disc | |
| CN104873631A (en) | Traditional Chinese medicinal composition for treating bone diseases, preparation method of traditional Chinese medicinal composition and bone disease therapeutic apparatus | |
| CN103110762A (en) | Traditional Chinese medicine composition for treating old fracture | |
| CN104225508A (en) | Traditional Chinese medicine composition for cervical spondylosis treatment and preparation method thereof | |
| CN103550380B (en) | Traditional Chinese medicine composition for treating hyperostosis | |
| CN103800840A (en) | Oral traditional Chinese medicine solution for treating cervical spondylosis | |
| CN105169279A (en) | Traditional Chinese medicine composition for treating knee joint bone hyperplasia | |
| CN104922363A (en) | Traditional Chinese medicine composite for treating osteoproliferation | |
| CN102579672A (en) | Medicament for treating bone hyperplasia and lumbar disc herniation | |
| CN105213766B (en) | A kind of dredging collateral supports knee soup and preparation method thereof | |
| CN101284087B (en) | Medicinal composition for curing lumbar disease | |
| CN103212044B (en) | Traditional Chinese medicine composition for treating cardiovascular diseases | |
| CN102018815A (en) | Chinese medicine preparation for treating tuberculosis of lumbar spine | |
| CN106511905A (en) | Traditional Chinese medicine preparation used for curing cervical spondylosis and preparation method thereof | |
| CN102028810B (en) | Traditional Chinese medicine for treating lumbar intervertebral disc protrusion | |
| CN102872287A (en) | Traditional Chinese medicine composition for treating femoral head necrosis and preparation method thereof | |
| CN1970067B (en) | Chinese medicinal formulation for treating vertebrae hyperosteogeny, protrusion of intervertebral disc and spinal stenosis | |
| CN101637535B (en) | Medicine for treating bone hyperplasia and preparation method thereof | |
| CN102058681A (en) | Traditional Chinese medicine for treating protrusion of lumbar vertebral disc and waist and leg pain and preparation method thereof | |
| CN101862430B (en) | Chinese medicament for treating femoral head necrosis and preparation method thereof | |
| CN106166275A (en) | A kind of decoction medicine treating chronic cervical syndrome and preparation method thereof | |
| CN106344793A (en) | Traditional Chinese medicine foot bath powder for treating arthritis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091209 Termination date: 20120815 |